Cargando…

Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso

BACKGROUND: Genetic polymorphisms in the human immune system modulate susceptibility to malaria. However, there is a paucity of data on the contribution of immunogenetic variants to malaria susceptibility in infants, who present differential biological features related to the immaturity of their ada...

Descripción completa

Detalles Bibliográficos
Autores principales:	Natama, Hamatandi Magloire, Rovira-Vallbona, Eduard, Krit, Meryam, Guetens, Pieter, Sorgho, Hermann, Somé, M. Athanase, Traoré-Coulibaly, Maminata, Valéa, Innocent, Mens, Petra F., Schallig, Henk D. F. H., Berkvens, Dirk, Kestens, Luc, Tinto, Halidou, Rosanas-Urgell, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885350/ https://www.ncbi.nlm.nih.gov/pubmed/33593344 http://dx.doi.org/10.1186/s12936-021-03628-y

Ejemplares similares

Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study
por: Natama, Hamtandi Magloire, et al.
Publicado: (2018)

Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing
por: Natama, Hamtandi Magloire, et al.
Publicado: (2017)

Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life
por: Natama, Hamtandi Magloire, et al.
Publicado: (2018)

Plasmodium falciparum sexual conversion rates can be affected by artemisinin-based treatment in naturally infected malaria patients
por: Portugaliza, Harvie P., et al.
Publicado: (2022)

Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2023)

Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
por: Noori, Navideh, et al.
Publicado: (2021)

Antibiotic susceptibility profile of bacterial isolates from febrile children under 5 years of age in Nanoro, Burkina Faso
por: Bonko, Massa dit Achille, et al.
Publicado: (2021)

Antibiotic Susceptibility of Staphylococcus aureus and Streptococcus pneumoniae Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
por: Bonko, Massa dit Achille, et al.
Publicado: (2021)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso
por: Ruizendaal, Esmée, et al.
Publicado: (2017)

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey
por: Lingani, Moussa, et al.
Publicado: (2020)

Implementation of a malaria rapid diagnostic test in a rural setting of Nanoro, Burkina Faso: from expectation to reality
por: Kiemde, Francois, et al.
Publicado: (2018)

Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2020)

Magnitude of low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso: a secondary data analysis
por: Lingani, Moussa, et al.
Publicado: (2021)

Diagnostic Performance of Plasmodium falciparum Histidine-Rich Protein-2 Antigen-Specific Rapid Diagnostic Test in Children at the Peripheral Health Care Level in Nanoro (Burkina Faso)
por: Bonko, Massa dit Achille, et al.
Publicado: (2022)

Polymorphisme de Plasmodium falciparum et mutations des gènes de résistance Pfcrt et Pfmdr1 dans la zone de Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2021)

Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique
por: Arnaldo, Paulo, et al.
Publicado: (2018)

Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
por: Sondo, Paul, et al.
Publicado: (2015)

Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2020)

Algorithms for sequential interpretation of a malaria rapid diagnostic test detecting two different targets of Plasmodium species to improve diagnostic accuracy in a rural setting (Nanoro, Burkina Faso)
por: Kiemde, Francois, et al.
Publicado: (2019)

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2015)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2020)

Age-modified factors associated with placental malaria in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2022)

Interleukin-10 and soluble tumor necrosis factor receptor II are potential biomarkers of Plasmodium falciparum infections in pregnant women: a case-control study from Nanoro, Burkina Faso
por: Ruizendaal, E., et al.
Publicado: (2017)

In Vivo Antiplasmodial Activity of Two Sahelian Plant Extracts on Plasmodium berghei ANKA Infected NMRI Mice
por: Bonkian, Léa Nadège, et al.
Publicado: (2018)

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
por: Tinto, Halidou, et al.
Publicado: (2014)

Treatable causes of fever among children under five years in a seasonal malaria transmission area in Burkina Faso
por: Kiemde, Francois, et al.
Publicado: (2018)

The effect of malaria rapid diagnostic tests results on antimicrobial prescription practices of health care workers in Burkina Faso
por: Bonko, Massa dit Achille, et al.
Publicado: (2019)

Author Correction: Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000–2016)
por: Rovira-Vallbona, Eduard, et al.
Publicado: (2023)

Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000–2016)
por: Rovira-Vallbona, Eduard, et al.
Publicado: (2023)

Household costs associated with seeking malaria treatment during pregnancy: evidence from Burkina Faso and The Gambia
por: Duval, Laetitia, et al.
Publicado: (2022)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Pathogens associated with acute diarrhea, and comorbidity with malaria among children under five years old in rural Burkina Faso
por: Lompo, Palpouguini, et al.
Publicado: (2021)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial
por: Birgersson, Sofia, et al.
Publicado: (2020)

Socioeconomic and environmental factors associated with malaria hotspots in the Nanoro demographic surveillance area, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol
por: Tahita, Marc Christian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_803fv8nrt9a9c4k6ih61rcu0in